Balaxi Pharmaceuticals gets nod to invest up to $4 million in Balaxi Global FZCO

12 Nov 2025 Evaluate

Balaxi Pharmaceuticals has received approval to invest up to $4 million as equity in its wholly owned subsidiary i.e Balaxi Global FZCO (Formerly known as Balaxi Global DMCC), Dubai. The objective for investment in WOS is to extend support for operational and business expansion requirements. The proposed investment would be completed on or before March 31, 2026.

The Board of Directors of the company, in their meeting held on November 11, 2025, has approved the same.

Balaxi Pharmaceuticals is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG products.


Peers
Company Name CMP
Redington 217.30
Adani Enterprises 1927.35
Amrapali Industries 14.50
Rashi Peripheral 342.10
PDS 260.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×